CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor
Joonhong Sohn, Ju Byung Chae, Sun Young Lee, Soo-Youl Kim, June-Gone Kim
Korean J Ophthalmol. 2010;24(1):29-34.   Published online February 5, 2010

Excel Download

A Novel Therapeutic Target in Inflammatory Uveitis: Transglutaminase 2 Inhibitor
Korean Journal of Ophthalmology. 2010;24(1):29   Crossref logo
Link1 Link2 Link3

Biological Therapies that Target Inflammatory Cytokines to Treat Uveitis
Advances in the Diagnosis and Management of Uveitis. 2019;   Crossref logo

Knockout of tissue transglutaminase ameliorates TGFβ2-induced ocular hypertension: A novel therapeutic target for glaucoma?
Experimental Eye Research. 2018;171:106-110   Crossref logo
Link1 Link2

Inflammatory monocytes—a novel therapeutic target for ALS?
Nature Reviews Neurology. 2012;8(10):533-533   Crossref logo
Link1 Link2 Link3

Complement inhibitor CD55 and progesterone receptors as a novel therapeutic target for lipoxin A4 in endotoxin mediated inflammatory stress
American Journal of Obstetrics and Gynecology. 2018;219(6):653-654   Crossref logo
Link1 Link2

Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors
Amino Acids. 2021;53(2):205-217   Crossref logo
Link1 Link2 Link3

The emerging role of miR-223 as novel potential diagnostic and therapeutic target for inflammatory disorders
Cellular Immunology. 2016;303:1-6   Crossref logo
Link1 Link2

Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease
Inflammatory Disorders - Part B. 2020;123-158   Crossref logo
Link1 Link2

Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis
Clinical Ophthalmology. 2011;1309   Crossref logo

Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target
Amino Acids. 2016;49(3):425-439   Crossref logo
Link1 Link2 Link3 Link4